Status:
COMPLETED
Study on Skin Toxicities Induced by Cancer Treatments
Lead Sponsor:
Institut Curie
Conditions:
Solid Tumor, Adult
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The skin toxicities will be evaluated on patient (male or female) with an indication of cancer treatment in the case of solid tumor of the breast, or lung.
Eligibility Criteria
Inclusion
- Patient, male or female, aged 18 years and older, with a solid tumor breast or lung, localized, locally advanced or not, metastatic or not;
- Patient in medical oncology consultation requiring systemic anti-tumor therapy (chemotherapy, targeted therapy, hormone therapy, immunotherapy) in neo-adjuvant, adjuvant or metastatic;
- Treatment planned for a minimum period of 3 months (from the date of inclusion);
- Having a social security protection;
- Signed informed consent form of the study.
Exclusion
- Patient treated for lymphoma, leukemia or inflammatory breast cancer ;
- Patient with a solid tumour which location is other than breast or lung;
- Patient with a tumor wound ;
- Patient with a general condition \> 2 at baseline (ECOG classification) ;
- Patient receiving anti-tumor treatment with radiotherapy exclusively or associated with concomitant radiotherapy ;
- Patient unable to receive information about the study and to give consent ;
- Persons deprived of liberty or guardianship ;
- Impossible submission to study procedures for geographical or psychological reasons.
Key Trial Info
Start Date :
November 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2024
Estimated Enrollment :
292 Patients enrolled
Trial Details
Trial ID
NCT04402606
Start Date
November 25 2020
End Date
April 15 2024
Last Update
April 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Curie
Paris, France, 75